Regulatory Controversies Surround Blood Glucose Monitoring Devices

Pinkos AF . FDA Meeting: Clinical Accuracy Requirements for Point of Care Blood Glucose Meters. J Diabetes Sci Technol 2010;(4)2: 496.

http://www.nytimes.com/packages/pdf/health/20090717_MONITOR_1.pdf [cited 2010 Jan 20].

http://www.iso.org/iso/iso_catalogue/catalogue_tc/catalogue_detail.htm?csnumber=26309 [cited 2010 Jan 20].

Fahy BG Coursin DB . An analysis: hyperglycemic intensive care patients need continuous glucose monitoring—easier said than done. J Diabetes Sci Technol. 2008;2 (2): 201–4.

Wiener RS Wiener DC Larson RJ . Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300 (8): 933–44.

Griesdale DE de Souza RJ van Dam RM Heyland DK Cook DJ Malhotra A Dhaliwal R Henderson WR Chittock DR Finfer S Talmor D . Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180 (8): 821–7.

Scott MG Bruns DE Sacks DB . Tight glucose control in critically ill adults. JAMA. 2008;300 (23): 2725–6.

Bellomo R Egi M . What is a NICE-SUGAR for patients in the intensive care unit? Mayo Clin Proc. 2009;84 (5): 400–2.

NICE-SUGAR Study Investigators Finfer S Chittock DR Su SY Blair D Foster D Dhingra V Bellomo R Cook D Dodek P Henderson WR Hébert PC Heritier S Heyland DK McArthur C McDonald E Mitchell I Myburgh JA Norton R Potter J Robinson BG Ronco JJ . Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360 (13): 1283–97.

Sacks DB . Intensive glucose control in the ICU: is SUGAR NICE? Nature Rev Endocrinol. 2009;5 (9): 473–4.

Van den Berghe G Schetz M Vlasselaers D Hermans G Wilmer A Bouillon R Mesotten D . Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab. 2009;94 (9): 3163–70.

Kanji S Buffie J Hutton B Bunting PS Singh A McDonald K Fergusson D McIntyre LA Hebert PC . Reliability of point-of-care testing for glucose measurement in critically ill adults. Crit Care Med. 2005;33 (12): 2778–85.

College of American Pathologists. CAP survey: participant summary for whole blood glucose survey 2008 set WBG-B. Northfield, IL: College of American Pathologists; 2008.

Boyd JC Bruns DE . Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. Clin Chem. 2001;47 (2): 209–14.

Boyd JC Bruns DE . Monte Carlo simulation in establishing analytical quality requirements for clinical laboratory tests meeting clinical needs. Methods Enzymol. 2009;467: 411–33.

Karon BS Deobald G Klee GG . Effect of different glucose meter error tolerances on dosing errors during intravenous insulin administration. Point Care. 2008;7: 124.

Boren SA Clarke WL . Analytical and clinical performance of blood glucose monitors. J Diabetes Sci Technol. 2010;4 (1): 84–97.

http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm176992.htm [cited 2010 Jan 20].

Schleis TG . Interference of maltose, icodextrin, galactose, or xylose with some blood glucose monitoring systems. Pharmacotherapy. 2007;27 (9): 1313–21.

Krouwer JS Cembrowski G . A review of standards and statistics used to describe blood glucose monitor performance. J Diabetes Science Technol. 2010;4 (1): 75–83.